[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338527-105":59,"doc-detail-338527-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","reprogramming-the-tumor-microenvironment-macrophages-emerge-as-key-players-in-breast-cancer-immunotherapy-mini-review","Reprogramming the tumor microenvironment - macrophages emerge as key players in breast cancer immunotherapy - mini review","","Reprogramming the tumor microenvironment is essential for understanding immune evasion in breast cancer, where tumor cells and a supportive niche drive resistance to therapy. The review highlights tumor-associated macrophages (TAMs) as plastic immune regulators that shift from anti-tumor M1 to pro-tumor M2 phenotypes under microenvironmental cues. It explains how TAM-mediated immunosuppression sustains relapse and poor outcomes and outlines therapeutic strategies, including engineered macrophages, M2 targeting drugs, and macrophage-based drug delivery.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/reprogramming-the-tumor-microenvironment-macrophages-emerge-as-key-players-in-breast-cancer-immunotherapy-mini-review/338527/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/reprogramming-the-tumor-microenvironment-macrophages-emerge-as-key-players-in-breast-cancer-immunotherapy-mini-review/338527.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role do tumor-associated macrophages (TAMs) play in breast cancer immunotherapy?","Question",{"text":112,"@type":113},"TAMs are key modulators because they can undergo phenotypic plasticity, shifting from M1 to M2 states. This shift supports immune evasion and contributes to therapy resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the tumor microenvironment (TME) promote immune suppression in breast cancer?",{"text":117,"@type":113},"The TME includes tumor cells, immune cells, reprogrammed stromal cells, and immunosuppressive components such as MDSCs and TAMs. Together they create an immunosuppressive niche that weakens innate immune responses and promotes T-cell and NK exhaustion.",{"name":119,"@type":110,"acceptedAnswer":120},"Which therapeutic approaches are suggested to target TAMs in breast cancer?",{"text":121,"@type":113},"The review discusses strategies such as engineered macrophages, M2-targeting drugs, and novel macrophage-mediated drug delivery methods. These approaches aim to improve immunotherapy efficacy and counter therapeutic resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338527,1790468175,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","TYPE Mini Review  \nPUBLISHED 26 November 2024 DOI 10.3389/fimmu.2024.1457491  \nOPEN ACCESS  \nEDITED BY  \nReem Amr Assal,  \nHeliopolis University, Egypt  \nREVIEWED BY  \nAlessandro Poggi,  \nSan Martino Hospital (IRCCS), Italy Haitao Wang,  \nNational Cancer Institute (NIH), United States Byungheon Lee,  \nKyungpook National University, Republic of Korea  \n*CORRESPONDENCE  \nAfsheen Raza  \n [Raza.afsheen@adu.ac.ae](Raza.afsheen@adu.ac.ae)  \nRECEIVED 30 June 2024  \nACCEPTED 07 November 2024  \nPUBLISHED 26 November 2024  \nCITATION  \nSami A and Raza A (2024) Reprogramming the tumor microenvironment – macrophages emerge as key players in breast cancer immunotherapy.  \nFront. Immunol. 15:1457491 .  \ndoi: 10.3389/fimmu.2024.1457491  \nCOPYRIGHT  \n© 2024 Sami and Raza. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) .  \nThe use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nReprogramming the tumor microenvironment – macrophages emerge as key players in breast cancer immunotherapy  \nAna Sami 1 and Afsheen Raza 2*  \n1 Department of Medicine and Dentistry, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom, 2 Department of Biomedical Sciences, College of Health Sciences, Abu Dhabi University, Abu Dhabi, United Arab Emirates  \nBreast cancer has the highest global incidence among all cancers, affecting more than 2 million individuals annually. Despite the availability of new drugs and novel treatment combinations, it is postulated that the incidence and mortality of breast cancer will rise by 40 . 8% and 51 . 9% respectively by 2040 . Such dire statistics are associated with the clonal evolution of cancer cells that leads to therapeutic resistance and consequent relapse in breast cancer patients. On the other hand, the tumor microenvironment (TME) comprising of tumor cells, cancer-associated immune cells, re-programmed stromal cells, and the extracellular matrix (ECM) creates an immunosuppressive niche facilitating immune evasion. This review focuses on a critical cellular component of the tumor microenvironment, the tumor-associated macrophages (TAMs) in breast cancer immunotherapy. Macrophages are inherently plastic and can convert from an anti-tumor M1 phenotype to a pro-tumor M2 phenotype based on microenvironmental cues. Cancer cells facilitate these cues, allowing the tumorassociated macrophages to gain M2 phenotype and mediate immune evasion. Therefore, knowledge of the distinct role of tumor-associated macrophages in immune evasion can help design therapeutics such as engineered macrophages, M2 targeting drugs, and novel macrophage-mediated drug delivery strategies for long-term survival in breast cancer.  \nKEYWORDS  \nimmunotherapy, breast cancer, tumor microenvironment, tumor-associated macrophages (TAMs), nanoparticle, epigenetics  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nBreast Cancer (BC) is a leading cause of morbidity and mortality in females affecting more than 2 million individuals annually (1) . This is due to multiple factors, the most important being tumoral heterogeneity.  \nBreast cancer heterogeneity, facilitated by clonal evolution of the tumor or by cancer stem cells (2) is associated with therapeutics that lead to the selection and propagation of drug-resistant clones, causing resistance to treatment modalities (3–5) . At least 20% of patients receiving treatment for breast cancer relapse within 5 years, resulting in metastatic disease with poor outcomes (6, 7) .  \nTo facilitate cancer progression and resistance to treatment modalities, tumor cells interact with various cellular components within the microenvir","cbCaijl4FcWDwiBZ","https://ap.wps.com/l/cbCaijl4FcWDwiBZ","pdf",952815,11,"English","# Introduction\n## Classically activated macrophages (M-1 phenotype)","[{\"question\":\"What role do tumor-associated macrophages (TAMs) play in breast cancer immunotherapy?\",\"answer\":\"TAMs are key modulators because they can undergo phenotypic plasticity, shifting from M1 to M2 states. This shift supports immune evasion and contributes to therapy resistance.\"},{\"question\":\"How does the tumor microenvironment (TME) promote immune suppression in breast cancer?\",\"answer\":\"The TME includes tumor cells, immune cells, reprogrammed stromal cells, and immunosuppressive components such as MDSCs and TAMs. Together they create an immunosuppressive niche that weakens innate immune responses and promotes T-cell and NK exhaustion.\"},{\"question\":\"Which therapeutic approaches are suggested to target TAMs in breast cancer?\",\"answer\":\"The review discusses strategies such as engineered macrophages, M2-targeting drugs, and novel macrophage-mediated drug delivery methods. These approaches aim to improve immunotherapy efficacy and counter therapeutic resistance.\"}]","Reprogramming the tumor microenvironment - macrophages emerge as key players in breast cancer immunotherapy - mini review | PDF",1790024058,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08ddc62339adef8ce1a87f7e228af32a.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/977320fe8f0da7279aa586efc50ba5d5.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c3bf26bcb3346020740fc8ae96cb872.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e364bfa9898d6687932241b683ea15f0.webp",980,692]